UK markets open in 21 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,462.65 +255.52 (+1.40%) CRUDE OIL
79.12 +0.17 (+0.22%) GOLD FUTURES
2,310.20 +0.60 (+0.03%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,335.95 +1,453.91 (+3.17%)
NeoGenomics, Inc. (NEO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 13.96 |
| Open | 14.03 |
| Bid | 14.70 x 600 |
| Ask | 14.76 x 300 |
| Day's range | 13.69 - 14.75 |
| 52-week range | 11.03 - 21.22 |
| Volume | |
| Avg. volume | 945,824 |
| Market cap | 1.88B |
| Beta (5Y monthly) | 1.10 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.66 |
| Earnings date | 30 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 20.64 |
Insider MonkeyNeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript April 30, 2024 NeoGenomics, Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.03. NEO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the NeoGenomics First Quarter 2024 Financial […]
Simply Wall St.NeoGenomics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
NeoGenomics ( NASDAQ:NEO ) First Quarter 2024 Results Key Financial Results Revenue: US$156.2m (up 14% from 1Q 2023...
- GuruFocus.com
NeoGenomics Inc (NEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...
Discover how NeoGenomics is navigating market dynamics with robust revenue growth and strategic expansions in clinical diagnostics.
© 2024 Yahoo. All rights reserved.